IGM Resins, a portfolio company of Arsenal Capital Partners and a provider of specialty materials for the coatings, inks, and adhesives markets, has acquired Insight High Technology Group, a manufacturer of photoinitiators and pharmaceutical intermediates.
“The union with IHT further strengthens IGM’s global position as a leader in photoinitiators and pharmaceutical intermediates,” said Sal Gagliardo, IGM Chairman and Operating Partner of Arsenal Capital Partners.
Insight High Technology (IHT) Group is a manufacturer of photoinitiators, pharmaceutical intermediates and fine chemicals. The company’s products are used in the UV curing, pharmaceutical and the fine and customized chemicals markets. IHT is based in China and has facilities in Beijing (headquarters), Tianjin and Jiangsu (www.iht.com.cn).
IGM Resins (IGM), acquired by Arsenal in September 2012, specializes in the development, manufacture and supply of products and technical services to the UV ink and coatings industry. IGM produces and distributes a range of radiation curable materials including acrylate oligomers and monomers, photoinitiators, and additives. The company has manufacturing facilities in the EU, USA, and Asia, supported by technical labs in the EU, USA, Asia, and South America. IGM is headquartered in the Netherlands (www.igmresins.com).
“We are very pleased that our long-time partner, IHT, has joined IGM,” said IGM Resins CEO Edward Frindt. “Their great strength in development of new materials, manufacturing capabilities and position in the Asia UV market combined with IGM’s market strength in the rest of the world creates a powerful organization offering depth and breadth of products and technical service to our global customers.”
Arsenal Capital Partners invests in middle-market specialty industrial and healthcare companies that have $50 million to $250 million in enterprise value. Industries of specific interest include specialty & fine chemicals; segments of healthcare; transportation and logistics; power generation; aerospace & defense; and process industry components and services. Arsenal has $1.7 billion of committed capital under management. The firm was founded in 2000 and has offices in New York and Shanghai (www.arsenalcapital.com).
2014 PEPD • Private Equity’s Leading News Magazine • 8-5-14